Global Cord Blood (NYSE:CO) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO) in a report issued on Sunday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

NYSE:CO opened at $1.25 on Friday. The company has a market capitalization of $151.94 million, a P/E ratio of 1.95 and a beta of 0.16. The firm has a 50-day moving average price of $1.45 and a two-hundred day moving average price of $1.36. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.